ATE475710T1 - Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs - Google Patents

Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs

Info

Publication number
ATE475710T1
ATE475710T1 AT99966445T AT99966445T ATE475710T1 AT E475710 T1 ATE475710 T1 AT E475710T1 AT 99966445 T AT99966445 T AT 99966445T AT 99966445 T AT99966445 T AT 99966445T AT E475710 T1 ATE475710 T1 AT E475710T1
Authority
AT
Austria
Prior art keywords
compositions
methods
therapy
cancer
diagnosis
Prior art date
Application number
AT99966445T
Other languages
English (en)
Inventor
Jennifer Mitcham
Gordon King
Paul Algate
Tony Frudakis
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/215,681 external-priority patent/US6528253B1/en
Priority claimed from US09/216,003 external-priority patent/US6670463B1/en
Priority claimed from US09/404,879 external-priority patent/US6468546B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE475710T1 publication Critical patent/ATE475710T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99966445T 1998-12-17 1999-12-17 Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs ATE475710T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/215,681 US6528253B1 (en) 1998-12-17 1998-12-17 Compositions and methods for diagnosis of ovarian cancer
US09/216,003 US6670463B1 (en) 1998-12-17 1998-12-17 Compositions and methods for therapy of ovarian cancer
US09/338,933 US6488931B1 (en) 1998-12-17 1999-06-23 Compositions and methods for therapy and diagnosis of ovarian cancer
US09/404,879 US6468546B1 (en) 1998-12-17 1999-09-24 Compositions and methods for therapy and diagnosis of ovarian cancer
PCT/US1999/030270 WO2000036107A2 (en) 1998-12-17 1999-12-17 Compositions and methods for therapy and diagnosis of ovarian cancer

Publications (1)

Publication Number Publication Date
ATE475710T1 true ATE475710T1 (de) 2010-08-15

Family

ID=26910274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966445T ATE475710T1 (de) 1998-12-17 1999-12-17 Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs

Country Status (5)

Country Link
US (1) US6488931B1 (de)
CN (1) CN101816788A (de)
AT (1) ATE475710T1 (de)
DE (1) DE69942637D1 (de)
NZ (2) NZ567750A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE413466T1 (de) * 1998-09-02 2008-11-15 Diadexus Inc Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
RS20050300A (en) 2002-10-16 2007-08-03 Euro-Celtique S.A., Antibodies that bind cell-associated ca 125/0772p and methods of use thereof
US7635560B2 (en) * 2003-04-17 2009-12-22 Genesis Group Inc. Pygopus in diagnosis and treatment of cancer
NZ568015A (en) 2005-12-08 2012-03-30 Medarex Inc Human monoclonal antibodies to O8E
CN106755406A (zh) * 2016-12-22 2017-05-31 亚能生物技术（深圳）有限公司 一种卵巢癌检测产品及试剂盒
CA3141229A1 (en) * 2019-06-28 2020-12-30 The Francis Crick Institute Limited Novel cancer antigens and methods
CN110499324A (zh) * 2019-09-02 2019-11-26 中生康元生物科技(北京)有限公司 一种用于鉴定肿瘤新抗原的细菌表达载体及筛选鉴定肿瘤新抗原的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2113440C1 (ru) * 1991-03-04 1998-06-20 Курихара Есие Фрагмент днк, кодирующий куркулин в с активностью модификатора вкуса, куркулин в с активностью модификатора вкуса и способ его получения

Also Published As

Publication number Publication date
NZ567750A (en) 2009-12-24
DE69942637D1 (de) 2010-09-09
NZ550860A (en) 2008-07-31
US6488931B1 (en) 2002-12-03
CN101816788A (zh) 2010-09-01

Similar Documents

Publication Publication Date Title
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
MXPA03000527A (es) Composiciones y metodos para la terapia y diagnostico de cancer ovarico.
WO2001008636A8 (en) Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
ATE209680T1 (de) Isolierte nukleinsäuremoleküle, peptide die mit hla-a2 moleküle (mhc) komplexe bilden, sowie deren verwendungen
DE60232102D1 (de) Zusammensetzungen und Verfahren zur WT1-spezifischen Immuntherapie
TR200103560T2 (tr) Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı
ATE299180T1 (de) Intrazellulare domäne des her-2/neu proteins, für die prevention oder behandlung von bösartigen tumoren
JPS6447392A (en) Monoclonal antibody
DE69840868D1 (de) Mage-3 peptide, die durch hla-klasse-ii molecule presentiert werden
DE3856180D1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
WO2002078516A3 (en) Compositions and methods for the therapy and diagnosis of cancer
ATE475710T1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
DE59712259D1 (de) E-Cadherin-Mutationen als Grundlage zur Diagnostik und Therapie humaner maligner Tumoren
ATE239035T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendungen
ES556684A0 (es) Un procedimiento para tratar celulas efectoras que tienen receptores de superficie para la region fc de un anticuerpo
ES2111757T3 (es) Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos.
DE60139150D1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
CY1108790T1 (el) Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου
ATE291738T1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
ATE209041T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendung
ATE291620T1 (de) Mammakarzinom-assoziiertes gen
WO1999054466A3 (en) Colon cancer-associated antigens and their diagnostic and therapeutic uses
BR9815775A (pt) Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade
ATE17190T1 (de) Mittel zur tumorlokalisierung und therapie mit markierten antikoerpern und antikoerperfragmenten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties